tiprankstipranks
Advertisement
Advertisement
Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
PremiumThe FlyAvalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
7d ago
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
Premium
The Fly
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
9d ago
Avalo Therapeutics Announces Major Equity and Warrant Offering
Premium
Company Announcements
Avalo Therapeutics Announces Major Equity and Warrant Offering
13d ago
Why Is Avalo Therapeutics Stock (AVTX) Up Today?
PremiumMarket NewsWhy Is Avalo Therapeutics Stock (AVTX) Up Today?
14d ago
Julian Harrison Raises AVTX Price Target to $58 on Strong Phase 2 LOTUS Data and Differentiated Safety Profile for Abdakibart
Premium
Ratings
Julian Harrison Raises AVTX Price Target to $58 on Strong Phase 2 LOTUS Data and Differentiated Safety Profile for Abdakibart
14d ago
Avalo Therapeutics Reports Strong Phase 2 Hidradenitis Data
Premium
Company Announcements
Avalo Therapeutics Reports Strong Phase 2 Hidradenitis Data
15d ago
Avalo Therapeutics initiated with an Outperform at Citizens
PremiumThe FlyAvalo Therapeutics initiated with an Outperform at Citizens
1M ago
Avalo Therapeutics price target raised to $40 from $25 at H.C. Wainwright
Premium
The Fly
Avalo Therapeutics price target raised to $40 from $25 at H.C. Wainwright
2M ago
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100